LIMN Liminatus Pharma, Inc.

Nasdaq liminatuspharma.com


$ 1.24 $ 0.00 (0 %)    

Monday, 10-Nov-2025 07:02:30 EST
QQQ $ 618.66 $ 0.00 (0 %)
DIA $ 471.67 $ 0.00 (0 %)
SPY $ 677.10 $ 0.00 (0 %)
TLT $ 89.40 $ 0.00 (0 %)
GLD $ 375.82 $ 0.00 (0 %)
$ 1.165
$ 1.28
$ 1.19 x 1,270
$ 1.24 x 1,100
-- - --
$ 1.11 - $ 33.66
397,596
na
27.15M
$ -1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-04-2025 06-30-2025 10-Q
2 05-31-2025 03-31-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-bl...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. has entered into a Memorandum of Understanding (MOU) to form a research and development consortium with ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION